Doctorglasses Chain Co.,Ltd. (SHE:300622)
China flag China · Delayed Price · Currency is CNY
27.37
+1.35 (5.19%)
May 15, 2026, 3:09 PM CST

Doctorglasses Chain Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
6,2367,0778,7303,4003,5273,918
Market Cap Growth
-10.96%-18.93%156.76%-3.60%-9.98%65.90%
Enterprise Value
5,7976,8328,7563,3903,5263,678
Last Close Price
27.3731.0638.2214.4214.8316.22
PE Ratio
39.6347.6284.2426.5546.5241.34
Forward PE
-29.1029.1029.1029.1029.10
PS Ratio
4.495.207.262.893.674.42
PB Ratio
6.487.6711.324.195.095.89
P/TBV Ratio
6.637.8611.674.515.216.04
P/FCF Ratio
23.1025.6234.9913.1119.3622.94
P/OCF Ratio
21.4223.8331.6912.1016.9218.28
EV/Sales Ratio
4.185.027.282.883.664.14
EV/EBITDA Ratio
27.8934.7762.3019.6836.0329.30
EV/EBIT Ratio
29.6736.9365.9121.4140.4031.63
EV/FCF Ratio
21.4824.7335.0913.0719.3621.53
Debt / Equity Ratio
0.540.200.340.200.250.31
Debt / EBITDA Ratio
2.490.940.980.550.750.81
Debt / FCF Ratio
1.920.671.040.630.961.20
Net Debt / Equity Ratio
-0.47-0.43-0.09-0.12-0.16-0.12
Net Debt / EBITDA Ratio
-2.19-2.02-0.49-0.55-1.14-0.65
Net Debt / FCF Ratio
-1.69-1.44-0.27-0.36-0.61-0.47
Asset Turnover
0.901.041.011.120.981.03
Inventory Turnover
2.102.782.612.632.542.79
Quick Ratio
2.791.971.201.751.951.77
Current Ratio
3.762.882.372.702.972.53
Return on Equity (ROE)
18.58%18.15%12.80%17.50%10.95%14.77%
Return on Assets (ROA)
7.94%8.86%6.99%9.43%5.55%8.42%
Return on Invested Capital (ROIC)
30.31%24.11%14.68%19.55%12.00%22.53%
Return on Capital Employed (ROCE)
14.00%18.60%15.20%17.40%11.20%15.00%
Earnings Yield
2.54%2.10%1.19%3.77%2.15%2.42%
FCF Yield
4.33%3.90%2.86%7.63%5.16%4.36%
Dividend Yield
--0.54%3.20%1.56%2.37%
Payout Ratio
4.29%17.99%141.94%47.08%125.61%71.04%
Buyback Yield / Dilution
-1.81%-0.12%-1.50%-0.46%0.03%-2.14%
Total Shareholder Return
-1.81%-0.12%-0.95%2.74%1.58%0.23%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.